FEATURED

PCa: The Potential of Radium-223

More evidence may be needed to understand the safety and efficacy of radium-223 in combination with abiraterone or enzalutamide.

Cancer Drug Addiction, Integrated Therapeutic Management

The drug addiction strategy must be broadened to account for non-addicted cells, sensitive or resistant, that remain after therapy.

ASH 2017 Coverage

Our complete coverage of the American Society of Hematology 2017 meeting in Atlanta, Georgia.

SABCS 2017 Coverage

Our complete coverage of the San Antonio Breast Cancer Symposium 2017 meeting.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Latest Features

The Potential of Radium-223 in Modern Prostate Cancer Treatment

The Potential of Radium-223 in Modern Prostate Cancer Treatment

More evidence may be needed to understand the safety and efficacy of radium-223 in combination with abiraterone or enzalutamide.

Cancer Drug Addiction: Prospects for Integrated Therapeutic Management

Cancer Drug Addiction: Prospects for Integrated Therapeutic Management

The drug addiction strategy must be broadened to account for non-addicted cells, sensitive or resistant, that remain after therapy. Much as selection should favor the development of drug resistant tumor cell lineages, it should also favor lineages that are resistant to addiction.

Potentially Inappropriate Medications May Shorten Survival Among Elderly Patients With Lymphoma

Potentially Inappropriate Medications May Shorten Survival Among Elderly Patients With Lymphoma

PIMs may cause drug-drug interactions, which can lead to treatment-related toxicities and consequently affect outcomes.

Comprehensive Smoke-free Ordinances Reduce Risk of Lung Cancer

Comprehensive Smoke-free Ordinances Reduce Risk of Lung Cancer

People living in counties with strong smoke-free policies were 7.9% less likely to be diagnosed with lung cancer compared with those living in counties with no protection.

Can Inhibiting Ubiquitin Target Undruggable Tumor Proteins?

Can Inhibiting Ubiquitin Target Undruggable Tumor Proteins?

A class of DUBs known as the ubiquitin-specific-processing proteases are involved in regulating the p53 signaling pathway and have been implicated in tumorigenesis and radiotherapy resistance.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters